결핵성 심낭염 진단에 있어 심낭액 림프구-포도당 비 = The Ratio Between the Percentage of Lymphocytes and Glucose Levels in Pericardial Fluid as a Method to Diagnose Tuberculous Pericarditis

다국어 초록 (Multilingual Abstract)

Background/Aims: Adenosine deaminase (ADA) is a valuable biochemical marker for pericardial effusion (PE) and may be useful for diagnosing tuberculous pericarditis (TPE) in patients with PE. However, no definite cut-off or borderline values for ADA currently exist to distinguish TPE from other PE etiologies. In this study, we identified other useful parameters and characterized their relationship with ADA as a method for diagnosing TPE. Methods: From June 2004 to November 2011, 42 patients underwent pericardiocentesis due to moderate or severe PE, as confirmed by echocardiography or chest computed tomography (CT). Patients were subdivided into TPE and non-TPE (NTPE) groups. We analyzed ADA (p) (the pericardial ADA) and %Lymph (p)/Glucose (p) (the ratio between the percentage of lymphocytes and glucose levels in PE). Results: We defined the cut-off value of ADA (p) as 48.5 IU/L, and that of %Lymph (p)/Glucose (p) as 0.678%·dL/mg. In a multivariate logistic regression analysis, an odds ratio (OR) of 44.24 and a 95% confidence interval (CI) of 2.85-686.97 were observed in patients with an ADA (p) ≥ 48.5 IU/L (p = 0.023). An OR of 20.39 and a 95% CI of 1.06-392.93 were observed in patients with a %Lymph (p)/Glucose (p) ≥ 0.678%·dL/mg (p = 0.046). The combination of ADA (p) and %Lymph (p)/Glucose (p) had a higher positive predictive value (PPV, 80.0%) and specificity (Sp, 93.8%) than either ADA (p) (PPV, 47.4%; Sp, 68.8%) or %Lymph (p)/Glucose (p) (PPV, 69.2%; Sp, 87.5%) alone. Conclusions: %Lymph (p)/Glucose (p) is a useful parameter for distinguishing TPE from other pericardial diseases if combined with an ADA (p) ≥ 48.5 IU/L. (Korean J Med 2012;83:458-467)

참고문헌 (Reference)

1 김대영, "중등도 이상의 심낭삼출 환자에서 임상상 및 장기예후" 대한내과학회 74 (74): 154-161, 2008

2 김성은, "심낭액에서 LDH의 진단적 가치" 대한내과학회 82 (82): 194-199, 2012

3 Mayosi BM, "Tuberculous pericarditis" 112 : 3608-3616, 2005

4 Park SY, "The usefulness of pericardial biopsy to evaluate the causes of pericardial disease" 29 : 517-522, 1999

5 Burgess LJ, "The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis" 122 : 900-905, 2002

6 Ahn JO, "Statistical Analysis of Biomedical Data Using SPSS 18.0. 1st ed., rev. 3" Hannarae Publishing Co 2011

7 Levy PY, "Molecular analysis of pericardial fluid: a 7-year experience" 27 : 1942-1946, 2006

8 Maisch B, "Guidelines on the diagnosis and management of pericardial diseases executive summary; the Task Force on the diagnosis and management of pericardial diseases of the European society of cardiology" 25 : 587-610, 2004

9 Barber LM, "Glucose level in pleural fluid as a diagnostic aid" 31 : 680-687, 1957

10 Park KS, "Diagnostic value of adenosine deaminase activity in tuberculous pericardial effusion" 20 : 141-147, 1990

11 Cherian G., "Diagnosis of tuberculous aetiology in pericardial effusions" 80 : 262-266, 2004

12 Sagristà-Sauleda J, "Diagnosis and management of pericardial effusion" 26 : 135-143, 2011

13 Reuter H, "Diagnosing tuberculous pericarditis" 99 : 827-839, 2006

14 Eo WK, "Clinical studies on the etiology and clinical course of pericardial effusions" 20 : 211-219, 1990

15 Augustin P, "Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis" 15 : 220-, 2011

16 Tripepi G, "Bias in clinical research" 73 : 148-153, 2008

17 Tuon FF, "Adenosine deaminase and tuberculous pericarditis: a systematic review with metaanalysis" 99 : 67-74, 2006

18 Syed FF, "A modern approach to tuberculous pericarditis" 50 : 218-236, 2007

19 Cho I, "A case of malignant pericardial mesothelioma misdiagnosed as tuberculosis pericarditis" 76 (76): 81-85, 2007